エピソード

  • Stephen R. Broderick, MD, MPHS - Integrating Immunotherapy in Resectable NSCLC: How to Move From Complexity Toward Clarity

    Stephen R. Broderick, MD, MPHS - Integrating Immunotherapy in Resectable NSCLC: How to Move From Complexity Toward Clarity
    2025/06/04
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/JSJ865. CME/MOC/CC/AAPA credit will be available until June 12, 2026.

    Integrating Immunotherapy in Resectable NSCLC: How to Move From Complexity Toward Clarity

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by independent educational grants from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc., Rahway, NJ, USA.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    58 分
  • Catherine Shu, MD, Gavitt Woodard, MD, FACS - Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care

    Catherine Shu, MD, Gavitt Woodard, MD, FACS - Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care
    2025/06/04
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/UKV865. CME/MOC/CC/AAPA credit will be available until June 13, 2026.

    Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an independent educational grant from AstraZeneca.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    51 分
  • Gerard A. Silvestri, MD, MS - Facilitating Progress in Early Detection and Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings

    Gerard A. Silvestri, MD, MS - Facilitating Progress in Early Detection and Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings
    2025/06/04
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/KDS865. CME/MOC/AAPA credit will be available until June 6, 2026.

    Facilitating Progress in Early Detection & Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings

    In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Association of Veterans' Research and Education Foundations. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    55 分
  • Nathan T. Connell, MD, MPH - Restoring Control in von Willebrand Disease: Collaborative Approaches for Delivering the Right Treatment for the Right Patient at the Right Time

    Nathan T. Connell, MD, MPH - Restoring Control in von Willebrand Disease: Collaborative Approaches for Delivering the Right Treatment for the Right Patient at the Right Time
    2025/06/04
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete NCPD/CE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CCN865. NCPD/CE/AAPA/IPCE credit will be available until May 22, 2026.

    Restoring Control in von Willebrand Disease: Collaborative Approaches for Delivering the Right Treatment for the Right Patient at the Right Time

    In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and National Bleeding Disorders Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    34 分
  • Neal D. Shore, MD, FACS - Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice

    Neal D. Shore, MD, FACS - Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice
    2025/05/20
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CBJ865. CME/AAPA/IPCE credit will be available until May 27, 2026.

    Personalizing Prostate Cancer Care: Real-World Approaches for the Community Urology Practice

    In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by educational grants from Astellas and Pfizer, Inc., Bayer HealthCare Pharmaceuticals Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    1 時間 4 分
  • Tanya Gupta, MD - Navigating the Clinical Integration of TROP2-Targeted ADCs in TNBC and HR+, HER2- Metastatic Breast Cancer: A Customized Learning Journey

    Tanya Gupta, MD - Navigating the Clinical Integration of TROP2-Targeted ADCs in TNBC and HR+, HER2- Metastatic Breast Cancer: A Customized Learning Journey
    2025/05/20
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/QJY865. CME/MOC/NCPD/AAPA credit will be available until May 13, 2026.

    Navigating the Clinical Integration of TROP2-Targeted ADCs in TNBC and HR+, HER2- Metastatic Breast Cancer: A Customized Learning Journey

    In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This program has been supported by an independent educational grant from Gilead Sciences, Inc.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    53 分
  • Sia Daneshmand, MD - Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum

    Sia Daneshmand, MD - Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum
    2025/05/16
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BYQ865. CME/MOC/AAPA/IPCE credit will be available until May 27, 2026.

    Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum

    In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Bladder Cancer Advocacy Network. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by independent educational grants from AstraZeneca, Daiichi Sankyo, Inc., Ferring Pharmaceuticals, Inc., and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    1 時間 27 分
  • Angela Hirbe, MD, PhD - Bridging Gaps, Shaping Lifelong NF1 Care: Team Strategies and Management Choices With MEK Inhibitors Across the Pediatric-to-Adult Care Continuum

    Angela Hirbe, MD, PhD - Bridging Gaps, Shaping Lifelong NF1 Care: Team Strategies and Management Choices With MEK Inhibitors Across the Pediatric-to-Adult Care Continuum
    2025/05/16
    This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.

    For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/EMS865. CME/AAPA/IPCE credit will be available until May 5, 2026.

    Bridging Gaps, Shaping Lifelong NF1 Care: Team Strategies & Management Choices With MEK Inhibitors Across the Pediatric-to-Adult Care Continuum

    In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and American Neurological Association. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Support
    This activity is supported by independent medical education grants from Alexion Pharmaceuticals and SpringWorks Therapeutics, Inc.

    Disclosure information is available at the beginning of the video presentation.

    続きを読む 一部表示
    50 分